Yu-Shih Yang

Yu-Shih Yang

Auto-generated profile, based on publicly available information

Yu-Shih Yang

Department of Obstetrics and Gynecology, National Taiwan University Hospital, Taipei 100, Taiwan; Department of Obstetrics and Gynecology, Fu Jen Catholic University Hospital, New Taipei 243, Taiwan

Research Focus & Metrics

Academic Career Length

43Years (1984-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 November 2007 in Human Reproduction
Verified
Journal Article
Open access
PDF file
Tsung-Hsien LeeTsung-Hsien Lee
Tsung-Hsien Lee
CLChung-Hsien Liu
Chung-Hsien Liu
CHChuin-Chia Huang
Chuin-Chia Huang
YWYi-Ling Wu
Yi-Ling Wu
YSYang-Tse Shih
Yang-Tse Shih
MLMaw-Shang Lee
Maw-Shang Lee
Anti-Müllerian hormone (AMH) is reported to be a reliable marker of the ovarian response to controlled ovarian stimulation (COS). The objective of this study is to determine whether the serum AMH level can predict ovarian hyperstimulation syndrome (OHSS) prior to selection of COS protocols. A cohort of 262 IVF cycles was investigated prospectively, in order to evaluate the predictive value for OHSS by means of certain risk factors, including age, body mass index (BMI), serum estradiol (E2) level, number of retrieved oocytes and basal serum AMH level. The basal serum AMH level predicted OHSS better than age and BMI with a sensitivity of 90.5% and specificity of 81.3%. Both the basal serum AMH level (odds ratio: 1.7856, P = 0.0003) and serum E2 level on the day of HCG administration (odds ratio: 1.0005, P = 0.0455) proved to be significant predictors of OHSS by logistic regression analysis. However, age (odds ratio: 0.9346, P = 0.049) was the only significant factor for prediction of clinical pregnancy. The basal serum AMH level could be utilized effectively to predict OHSS and thus to direct the selection of mild COS protocols.

1 June 2007 in Hypertension
Verified
Journal Article
Closed access
MCMei-Jou Chen
Mei-Jou Chen
WYWei-Shiung Yang
Wei-Shiung Yang
JYJehn-Hsiahn Yang
Jehn-Hsiahn Yang
CCChi-Ling Chen
Chi-Ling Chen
HHHong-Nerng Ho
Hong-Nerng Ho
YYYu-Shih Yang
Yu-Shih Yang
The role of testosterone on the development of hypertension is controversial, especially in women with polycystic ovary syndrome (PCOS) who have higher prevalence of obesity and insulin resistance than women without PCOS. Little is known about the association between serum testosterone level and blood pressure in young women with PCOS. In the 151 young Taiwanese women with PCOS enrolled in this cross-sectional study, we measured the body mass index, waist circumference, blood pressure, fasting glucose, fasting insulin, lipid profile, and hormone profiles. The free androgen index, total testosterone, and sex hormone-binding globulin, but not the level of dehydroepiandrosterone sulfate, significantly correlated with both systolic blood pressure (SBP) and diastolic blood pressure (DBP). In multiple linear regression models adjusted for age, body mass index, and other anthropometric, metabolic, and hormonal variables, the level of serum free androgen index or total testosterone, but not the sex hormone-binding globulin, were independently related to SBP and DBP. The age- and body mass index–adjusted least-square mean of serum-free androgen index levels were significantly different between the highest quartile and other quartiles of the SBP and DBP levels. The high bioavailable testosterone levels (free androgen index: ≥19%) in women with PCOS increased the risk of elevated blood pressure (SBP ≥130 mm Hg and/or DBP ≥85 mm Hg) with an odds ratio of 3.817 ( P =0.029; 95% CI: 1.14 to 12.74) after adjustment for age, anthropometric measures, and metabolic profiles. Our results suggest that the characteristic hyperandrogenemia in young women with PCOS was associated with an elevated SBP and DBP independent of age, insulin resistance, obesity, or dyslipidemia.

1 December 1997 in American Journal of Reproductive Immunology
Verified
Journal Article
Closed access
PDF file
HHHong‐Nerng Ho
Hong‐Nerng Ho
MWMing‐Yih Wu
Ming‐Yih Wu
YYYu‐Shih Yang
Yu‐Shih Yang

1 April 2003 in Molecular and Cellular Endocrinology
Verified
Journal Article
Closed access
SCS.U. Chen
S.U. Chen
YLY.R. Lien
Y.R. Lien
KCK.H. Chao
K.H. Chao
HHH.N. Ho
H.N. Ho
YYY.S. Yang
Y.S. Yang
TLT.Y. Lee
T.Y. Lee

31 January 2008 in Human Reproduction
Verified
Journal Article
Open access
PDF file
MCMei-Jou Chen
Mei-Jou Chen
WYWei-Shiung Yang
Wei-Shiung Yang
CCChi-Ling Chen
Chi-Ling Chen
MWMing-Yih Wu
Ming-Yih Wu
YYYu-Shih Yang
Yu-Shih Yang
HHHong-Nerng Ho
Hong-Nerng Ho
Anti-Müllerian hormone (AMH) is a biomarker that predicts the number of antral follicles and is involved in follicle arrest for women with polycystic ovary syndrome (PCOS). We investigated the association between the characteristic hyperandrogenemia, insulin resistance (IR), AMH, and the morphology and size of ovaries for women with PCOS. A total of 99 Taiwanese women with PCOS who were willing to undergo vaginal ultrasonography were enrolled in this cross-sectional study. The number of antral follicles and the ovarian volume showed a significant correlation with AMH, total testosterone and the free androgen index, but not with age, body mass index (BMI) or the homeostasis model assessment of insulin resistance (HOMA-IR). AMH had a significant negative association with both BMI and HOMA-IR. Multiple stepwise regression analysis demonstrated that AMH, BMI and total testosterone were independently related to the number of antral follicles. AMH and total testosterone were the main determinants for ovarian volume in a stepwise regression model. Our results suggest that not only the AMH level, but also obesity, IR and elevated androgen levels may relate to the development of the large size of antral follicle pool and ovarian volume in women with PCOS. Obesity and IR may enhance the follicular excess through the dysregulation of AMH or through the pathway of hyperandrogenemia. These findings might partly explain why adequate body weight management and improvement in IR can improve the ovulatory function for women with PCOS.

1 June 2013 in Fertility and Sterility
Verified
Journal Article
Closed access
JYJehn-Hsiahn Yang
Jehn-Hsiahn Yang
MCMei-Jou Chen
Mei-Jou Chen
CCChin-Der Chen
Chin-Der Chen
SCShee-Uan Chen
Shee-Uan Chen
HHHong-Nerng Ho
Hong-Nerng Ho
YYYu-Shih Yang
Yu-Shih Yang